Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients

doi:10.5527/wjn.v4.i3.388

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12111)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

811

WORD

457

HTML

5845

Figures (1-2)

392

Tables (1-3)

189

Sum=7694

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

373

Download

1237

Sum=1610

Publishing Process of This Article

Item

Count

Browse

1255

Download

1552

Sum=2807

Jul 6, 2015 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Nephrol. Jul 6, 2015; 4(3): 388-395
Published online Jul 6, 2015. doi: 10.5527/wjn.v4.i3.388

Full Size Figure Download Figure

Figure 2 Flow chart for management of chronic kidney disease in human immunodeficiency virus-infected patients. This algorithm includes a clinical flow from screening of risk factors to identification, evaluation and follow-up care of patients for prevalent or incident CKD. CKD: Chronic kidney disease; HTN: Hypertension; DM: Diabetes mellitus; eGFR: Estimated glomerular filtration rate; NAG: N-acetyl-D-glucosaminidase; M: Microglobulin; ART: Anti-retroviral therapy; ATV: Atazanavir; TDF: Tenofovir disoproxil fumarate.

Citation: Ando M, Yanagisawa N. Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients. World J Nephrol 2015; 4(3): 388-395
URL: https://www.wjgnet.com/2220-6124/full/v4/i3/388.htm
DOI: https://dx.doi.org/10.5527/wjn.v4.i3.388